Ceribell, Inc.
CBLLNasdaqCIK 1861107HealthcareFiscal year ends Dec 31
Reports and events: 39 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1020:50 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342574 |
| 2026-08-1020:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342463 |
| 2026-07-3023:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-324378 |
| 2026-06-0220:19 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-253558 |
| 2026-05-1120:49 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-217008 |
| 2026-05-1120:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216821 |
| 2026-04-2016:18 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001193125-26-163290 |
| 2026-02-2421:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-067238 |
| 2026-02-2421:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-067136 |
| 2026-01-0515:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-001800 |
| 2026-01-0221:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-000994 |
| 2025-12-1218:13 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-317295 |
| 2025-12-0914:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-312035 |
| 2025-11-2413:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-292140 |
| 2025-11-0421:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264882 |
| 2025-11-0421:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264699 |
| 2025-09-2416:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-214813 |
| 2025-09-2213:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-210195 |
| 2025-08-0520:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103142 |
| 2025-08-0520:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103052 |
| 2025-07-0721:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-094303 |
| 2025-06-2016:45 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-088309 |
| 2025-06-1215:50 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-085227 |
| 2025-05-0820:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067097 |
| 2025-05-0820:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066974 |
| 2025-04-3014:45 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0000950170-25-060705 |
| 2025-04-1112:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-053034 |
| 2025-03-1418:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-039317 |
| 2025-02-2521:37 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026773 |
| 2025-02-2521:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026668 |
| 2025-01-1315:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004633 |
| 2024-11-1221:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125409 |
| 2024-11-1221:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125371 |
| 2024-10-2220:20 ET | SC 13D | Ownership report, active investor | 0001193125-24-241076 |
| 2024-10-1521:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114767 |
| 2024-10-0911:38 ET | S-1/A | Registration statement, amended | 0000950170-24-113629 |
| 2024-10-0710:19 ET | S-1/A | Registration statement, amended | 0000950170-24-113073 |
| 2024-09-1920:32 ET | S-1/A | Registration statement, amended | 0000950170-24-108128 |
| 2024-08-2620:43 ET | S-1 | Registration statement | 0000950170-24-100574 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.